Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
DNA similar filings
- 12 Jan 22 Ginkgo Bioworks Provides Preliminary Unaudited 2021 Revenue Highlights and Business Review
- 24 Nov 21 Index to Financial Statements
- 15 Nov 21 Ginkgo Bioworks Reports Third Quarter 2021 Results
- 20 Sep 21 Entry into a Material Definitive Agreement
- 14 Sep 21 Submission of Matters to a Vote of Security Holders
- 14 Sep 21 Regulation FD Disclosure
- 8 Sep 21 Regulation FD Disclosure
Filing view
External links
Exhibit 16.1
September 17, 2021
Office of the Chief Accountant
Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Ladies and Gentlemen:
We have read Ginkgo Bioworks Holdings, Inc. statements (formerly known as Soaring Eagle Acquisition Corp.) included under Item 4.01 of its Form 8-K dated September 17, 2021. We agree with the statements concerning our Firm under Item 4.01, in which we were informed of our dismissal on September 16, 2021. We are not in a position to agree or disagree with other statements contained therein.
Very truly yours,
/s/ WithumSmith+Brown, PC
New York, New York